John Dodd

John Dodd, PhD, has 40 years of experience in the discovery and development of clinically relevant drugs. Prior to joining Palatin, Dodd was a director in immunology chemistry at Bristol-Myers Squibb, and before that rose to research fellow at the Robert Wood Johnson Pharmaceutical Research Institute (J&J).